Glucamine compounds for treating hepatitis virus infections

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 31/045 (2006.01) A61K 31/047 (2006.01) A61K 31/12 (2006.01) A61K 31/137 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2362785

N-Substituted glucamine compounds of Formula (I) are effective in treatment of hepatitis infections, including hepatitis B and hepatitis C. In treating hepatitis infections, the compounds of Formula (I) may be used alone, or in combination with another antiviral agent selected from among nucleosides, nucleotides, immunomodulators, immunostimulants or various combinations of such other agents.

La présente invention concerne des composés glucamine N-substitués de formule (I) qui sont efficaces dans le traitement d'hépatites, y compris d'hépatites B et C. Lors du traitement des hépatites, les composés de formule (I) peuvent être utilisés seuls ou en combinaison avec un autre agent antiviral choisi parmi des nucléosides, des nucléotides, des immunomodulateurs, des immunostimulants, ou des combinaisons variées de tels agents.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glucamine compounds for treating hepatitis virus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucamine compounds for treating hepatitis virus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucamine compounds for treating hepatitis virus infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1572863

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.